investment

Novo Nordisk’s stock rallies after drugmaker reveals deal with OpenAI

Jaimy Lee

1 min read

0 likes

Quantum News · Media Library

Understand this faster with AI

Ask ChatGPT

Research with Perplexity

Explain with Claude

Discuss on Grok

Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its workforce.

Read Original

Source Information

Source: MarketWatch

Website: https://www.marketwatch.com/rss/topstories

Discussion

0 professional contributions

Be the first to add a constructive contribution.